First Tracks Biotherapeutics Inc

Chart & performance

D1W1MN

P/E

—

P/S

—

EPS

Div yield, %

—

Shrs. gr., 5y

—

Rev. gr., 5y

Revenues

Net income

CFO

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

First Tracks Biotherapeutics, Inc. is a clinical-stage biotechnology firm focused on advancing antibody therapies. These innovative treatments are designed to modulate immune system pathways that contribute to autoimmune and inflammatory diseases. The company, founded in 2025, has its headquarters in San Diego, California, and operates as a subsidiary of AnaptysBio, Inc.

URL

IPO date

Apr 06, 2026

Employees

Domiciled in

Incorporated in

Valuation

No data to show